Risk-based monitoring (RBM) and risk-based quality management (RBQM) are “central to ensuring the safety of patients in clinical trials, and [are] expected to continue to grow in importance as [trials] […]
With its recently issued qualification opinion on the use of electronic source direct data capture (eSource DDC) in clinical trials, the European Medicines Agency (EMA) has, likely to the […]
Enlightened souls maintain it’s better to give than to receive—and two leading clinical trial practitioners at the Duke Clinical Research Institute (DCRI) think it’s high time an industry so dependent […]
“It’s time for perception to meet reality” regarding some common notions clinical trial stakeholders have about using health management apps during studies, according to Aaron Fleishman, director of market development […]
One of the leading academic medical centers in New England has successfully leveraged adaptive business intelligence to foster change and significantly streamline clinical trial operations, a program leader told attendees […]